🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/08/2007 15,36 15,78 15,36 15,66 +1,95% 2,73% 20.150
24/08/2007 14,94 15,84 14,94 15,36 +2,81% 6,02% 35.917
23/08/2007 15,06 15,12 14,88 14,94 -0,80% 1,59% 30.350
22/08/2007 15,24 15,48 14,76 15,06 -0,40% 4,72% 45.000
21/08/2007 15,00 15,30 14,94 15,12 +0,80% 2,40% 31.650
20/08/2007 15,42 15,48 14,94 15,00 -2,72% 3,50% 48.050
17/08/2007 15,66 15,66 15,06 15,42 +1,98% 3,83% 40.183
16/08/2007 15,30 15,96 15,00 15,12 -2,33% 6,27% 43.783
15/08/2007 15,60 16,02 15,42 15,48 -2,27% 3,85% 52.850
14/08/2007 16,08 16,32 15,78 15,84 -2,22% 3,36% 60.750
13/08/2007 17,34 17,34 16,02 16,20 -4,59% 7,61% 61.367
10/08/2007 16,14 17,40 15,84 16,98 +0,71% 9,67% 77.017
09/08/2007 15,84 16,98 15,72 16,86 +3,31% 7,95% 58.733
08/08/2007 15,60 16,74 15,60 16,32 +3,82% 7,31% 103.500
07/08/2007 15,72 16,08 15,54 15,72 +0,00% 3,44% 36.733
06/08/2007 15,36 16,08 15,30 15,72 +1,95% 5,08% 55.233
03/08/2007 15,96 16,02 15,42 15,42 -3,02% 3,76% 43.033
02/08/2007 16,02 16,38 15,78 15,90 -0,75% 3,75% 46.850
01/08/2007 15,42 16,02 15,30 16,02 +2,69% 4,67% 61.683
31/07/2007 16,80 16,80 15,42 15,60 -4,41% 8,21% 103.117
30/07/2007 16,14 16,38 15,78 16,32 +1,49% 3,72% 79.083
27/07/2007 16,80 16,86 15,72 16,08 -4,29% 6,79% 127.717
26/07/2007 16,86 16,92 16,26 16,80 +0,00% 3,91% 113.567
25/07/2007 17,58 17,70 16,26 16,80 -1,75% 8,19% 127.417
24/07/2007 17,16 17,16 16,50 17,10 -0,35% 3,85% 102.067
23/07/2007 16,98 17,22 16,80 17,16 +1,42% 2,47% 73.567
20/07/2007 16,98 17,22 16,74 16,92 +1,08% 2,83% 60.467
19/07/2007 16,86 17,22 16,56 16,74 +0,36% 3,91% 69.633
18/07/2007 17,10 17,22 16,62 16,68 -3,14% 3,51% 92.700
17/07/2007 18,48 18,48 17,04 17,22 +1,41% 7,79% 226.650